Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), most commonly known as Crohn’s disease (CD) and ulcerative disease (UC), is a chronic and relapsing intestinal disease which cannot be cured completely. The prevalence of IBD in Europe and in North America has increased over the past 20 years. As most IBD patients a...
Saved in:
| Main Authors: | Qiyue Wang, Shuyi Mi, Zixuan Yu, Qiyi Li, Jiacai Lei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2020/7397523 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunoglobulin Therapy in Inflammatory Bowel Disease
by: Douglas S Levine
Published: (1993-01-01) -
Trends in Inflammatory Bowel Disease Therapy
by: L Sutherland, et al.
Published: (1990-01-01) -
Inflammatory bowel disease and nutritional support therapy
by: Zhi-Han XU, et al.
Published: (2022-08-01) -
INVITED COMMENTARY on Andersen S, et al. Developmental Windows of Environmental Vulnerability for Inflammatory Bowel Disease
by: David A. Simon, DO, et al.
Published: (2024-03-01) -
Update of Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein
Published: (1994-01-01)